A proteolysis-resistant MRI-visible nanoparticle formulation of GLP-1RA (nano-GLP-1RA) was engineered to target GLP-1Rexpressing cells within atherosclerotic lesions ( In ApoE/ mice, nano-GLP-1RA selectively accumulated in plaque-resident inflammatory and de-differentiated smooth muscle cells, consistent with GLP-1Rexpressing populations observed in human plaques ( Taken together, while imaging and omics technologies offer powerful tools to characterize vascular biology, their integration with GLP-1RA therapy for patient stratification remains an emerging concept that requires further clinical validation
Text or call our office 312-846-1629 to get your free consultation today
10.1038/nchembio.1416 31 DollS.FreitasF
For anyone who needs to purchase the right products for their research, you can explore our full catalog of research compounds and be confident in the quality of our products
Services are available in all 50 states, with clear pricing, secure medical records, and no insurance required
As we have seen, semaglutide, a GLP-1 receptor agonist known for its efficacy in managing type 2 diabetes and obesity, may also impact hormonal balance, particularly in patients undergoing hormone replacement therapy (HRT)
